Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.79 USD
Change Today +0.005 / 0.64%
Volume 14.9K
TTNP On Other Exchanges
As of 10:59 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc Rubin M.D.

Executive Chairman and Member of Executive Committee, Titan Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 4 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Marc Rubin, M.D., Founded Titan Pharmaceuticals Inc. and served as its Chief Executive Officer and President from October 1, 2007 to December 2008. Dr. Rubin is a Biopharmaceutical Consultant. He joined Titan in October 2007. He served as a Member of Executive Board at Bayer Pharma AG (formerly, Schering Aktiengesellschaft) from October 1, 2003 to February 2007, its Member of Board of Management from September 14, 2006 to January 2007 and also served as its Head ...

Read Full Background

Corporate Headquarters*

400 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-244-4990
Fax: 650-244-4956

Board Members Memberships*

Executive Chairman and Member of Executive Committee
Director, Member of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Science & Technology Committee
Lead Independent Director and Member of Compensation Committee


MD 1980
Weill Cornell Medical College, New York

Other Affiliations*

Annual Compensation*

Total Annual Compensation$210,000

Stock Options*

Restricted Stock Awards$66,000
Exercisable Options1,860,000
Unexercisable Options75,000
Total Number of Options1,935,000

Total Compensation*

Total Annual Cash Compensation$210,000
Total Short Term Compensation$210,000
Other Long Term Compensation$66,000
Total Calculated Compensation$276,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TTNP:US $0.79 USD +0.005


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Rakesh Kapoor Chief Executive Officer, Executive Director and Member of Nomination Committee
Reckitt Benckiser Group plc
3.5M GBP
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TITAN PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at